Replies to post #10636 on IntelGenx Technologies Corp (IGXT)

[specular]

Thanks for posting the new presentation - wish I could say I was impressed. I didn't see anything that would significantly contribute to increase revenue for 2 years - and the Suboxone launch with PAR is still subject to a court ruling.

Also very disappointed in no meaningful movement on the INT0028 project (Neuropathic Pain) - they have such a strong patent position on this, and the N Pain category is huge and growing. The other head scratcher for me is that they have made no progress on the animal health side.